Do we have to discuss the guidelines about therapeutic strategy in systolic heart failure with reduced ejection fraction?

Session DPC / CPD Session

Jeudi 18 Janvier 2018   08:30-10:00   Bordeaux Amphitheatre
Main session
08:30 • Damien Logeart
Which role for angiotensin receptor-neprilysin inhibitors?
08:50 • Yves Juillière
Which place for ivabradine and digoxine?
Should we implant cardiac defibrillator in all patients with LVEF ≤ 35%?
09:30 • Erwan Flécher
What place for cardiac assistance?